Skip to Content
Translational Research Program (TRP)
Last Updated: 09/22/16

Endometrial SPOREs

Endometrial cancer is the most common cancer of the female reproductive system and accounts for approximately 6 percent of all cancers in women in the United States. Endometrial cancer is typically diagnosed in women aged 45-74, and approximately 60,050 new cases and 10,470 deaths are estimated in the United States in 2016. The first Endometrial SPORE was funded in 2003, and the currently funded Endometrial SPORE at MD Anderson supports four projects focused on developing therapeutic strategies for advanced/recurrent endometrial cancer and aggressive subtypes, addressing unmet clinical needs in prevention and conservative therapy of high-risk precancerous lesions and low grade endometrial cancer, and incorporation of molecular diagnostics into clinical decision-making. The annual symposium organized by the MDACC Endometrial SPOREs reaches out to investigators within the United States and abroad to help support and unify translational activities within this cancer site.

University of Texas/MD Anderson

Karen H. Lu, MD [Click Here]
Professor and Chair
Department of Gynecologic Oncology
University of Texas
MD Anderson Cancer Center
1515 Holcombe Boulevard, Unit 1362
Houston, TX 77030
Tel: (713) 745-8902
Fax: (713) 792-7586
Email: khlu@mdanderson.org

For more information on this specific SPORE’s institution, please visit:
https://www.mdanderson.org/research/departments-labs-institutes/spores/uterine-cancer-spore.html